Supplements and Featured Publications
Novel Targets in the Ovarian Cancer Treatment Paradigm
Volume: 1
Issue: 1
The Novel Targets in the Ovarian Cancer Treatment Paradigm publication covers some of the latest practice-changing advances as it relates to novel targets in the treatment for patients with advanced ovarian cancer.
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5